How do enzyme degradation risks affect strip shelf-life procurement decisions?

Glucose oxidase–based strips typically carry 18–24 month expiry windows when stored below 30 °C. Buyers in tropical climates should prioritize GDH-FAD enzyme variants that offer superior heat stability [15]. Read More

What toll-manufacturing options exist for private-label strip programs?

Nipro, ACON, and several Taiwanese OEMs offer white-label strip production with minimum order quantities starting at 5 million units per SKU. Contract terms typically include exclusive regional distribution rights [11]. Read More

How do IVDR Class D reclassification timelines impact European market entry?

Self-test glucose diagnostic strips must fully comply with tougher Class C IVDR guidelines by December 31, 2028, requiring complete notified-body technical file assessments and robust clinical performance documentation to protect market authorization across Europe. Read More

Can strip-based ketone monitoring replace laboratory beta-hydroxybutyrate assays?

Capillary blood ketone strips achieve ≥95% concordance with serum assays at concentrations above 0.5 mmol/L. Clinical guidelines still recommend lab confirmation for diabetic ketoacidosis diagnosis [23]. Read More

What reimbursement coding applies to multi-analyte strip panels in the US?

Multi-analyte strips currently lack a dedicated HCPCS code, requiring providers to bill individual analyte codes separately. CMS is evaluating a bundled code proposal for 2027 implementation [12]. Read More

How does strip accuracy compare across major ISO 15197:2013 certified brands?

ISO 15197:2013 mandates ±15% accuracy at glucose levels above 100 mg/dL. Independent trials show Contour Next and Accu-Chek Guide consistently outperforming this threshold by 5–8 percentage points [23]. Read More

What strip-disposal regulations affect hospital procurement compliance?

Used strips qualify as regulated medical waste under OSHA Bloodborne Pathogen Standards, requiring sharps-adjacent disposal containers. EU hospitals must additionally comply with Waste Framework Directive classification [25]. Read More

Test Strip Market (2026 - 2035)

ID: MRFR/MED/0201-HCR

150 Pages

Nidhi Mandole

Last Updated: July 23, 2026

Test Strip Market Research Report Information by Product Type (Urine Test Strip, Diabetic Strips, and Fluorescein), by Application (Disease Diagnosis [Urinalysis [Urinary Tract Infection (UTI), Liver Disease, Kidney Disease, Diabetic Test, and Others] Blood Glucose Analysis, Ophthalmic Diagnosis)] Pregnancy Test) by Function (Visual Test Strips and Automated Test Strips), by End User (Institutes & Research Laboratories, Hospital & Clinics, and Diagnostic Laboratories), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2035

Test Strip Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)3.92%

2025 Market SizeUSD 17.86 Billion

2035 Market SizeUSD 26.24 Billion

Key Players

Roche Diagnostics

Abbott Laboratories

Ascensia Diabetes Care

LifeScan Inc.

Siemens Healthineers

Arkray Inc.

Trends

Rising Global Diabetes Prevalence
Government Screening Mandates
Digital Health and Connected Strip Ecosystems

Opportunities

Multi-Analyte Strip Platforms
E-Pharmacy and Direct-to-Consumer Distribution
Emerging-Market Screening Infrastructure

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Global Diabetes Prevalence | |
  2. 3.1.2 Government Screening Mandates | |
  3. 3.1.3 Digital Health and Connected Strip Ecosystems | |
  4. 3.1.4 Expansion of Home-Based Wellness Testing | |
  5. 3.1.5 Aging Population Demographics | |
  6. 3.1.6 Multi-Analyte Strip Innovation | |
  7. 3.1.7 Retail Pharmacy Channel Expansion |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 CGM Cannibalization of Glucose Strips | |
  2. 3.2.2 Pricing Pressure from Payer Reimbursement Cuts | |
  3. 3.2.3 Counterfeit and Grey-Market Strips | |
  4. 3.2.4 EU IVDR Compliance Costs for Smaller OEMs | |
  5. 3.2.5 Enzyme Substrate Supply-Chain Concentration |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Multi-Analyte Strip Platforms | |
  2. 3.3.2 E-Pharmacy and Direct-to-Consumer Distribution | |
  3. 3.3.3 Emerging-Market Screening Infrastructure | |
  4. 3.3.4 Data Monetization Through Connected Diagnostics | |
  5. 3.3.5 Decentralized Clinical Trials |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Test Strip Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product | |
  1. 5.1.1 Blood Test Strips | |
  2. 5.1.2 Urine Test Strips |
2. 5.2 By Application | |
  1. 5.2.1 Diabetes | |
  2. 5.2.2 Pregnancy Detection | |
  3. 5.2.3 Urinary Tract Infection | |
  4. 5.2.4 Other Applications |
3. 5.3 By End User | |
  1. 5.3.1 Hospitals & Clinics | |
  2. 5.3.2 Homecare / Personal Use | |
  3. 5.3.3 Other End Users |
4. 5.4 By Distribution Channel | |
  1. 5.4.1 Hospital Pharmacies | |
  2. 5.4.2 Retail Pharmacies | |
  3. 5.4.3 Online Pharmacies | |
  4. 5.4.4 Other Channels
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Roche Diagnostics | |
  2. 7.3.2 Abbott Laboratories | |
  3. 7.3.3 Ascensia Diabetes Care | |
  4. 7.3.4 LifeScan Inc. | |
  5. 7.3.5 Siemens Healthineers | |
  6. 7.3.6 Arkray Inc. | |
  7. 7.3.7 ACON Laboratories | |
  8. 7.3.8 Trividia Health | |
  9. 7.3.9 Nipro Corporation | |
  10. 7.3.10 B. Braun Melsungen
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Enhanced Point-of-Care Diagnostics |
2. 8.2 Platform Economics and Razor-Razorblade Evolution |
3. 8.3 Sustainability and Green Manufacturing |
4. 8.4 Decentralized and Preventive Care Models
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Test Strip Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Test Strip Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Test Strip Market – Driver Impact Analysis |
TABLE 4 Global Test Strip Market – Restraints Impact Analysis |
TABLE 5 Global Test Strip Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 6 Global Test Strip Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 7 Global Test Strip Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Global Test Strip Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 9 Global Test Strip Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 10 North America Test Strip Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Europe Test Strip Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 Asia-Pacific Test Strip Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 South America Test Strip Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Middle East & Africa Test Strip Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 15 Competitive Benchmarking Matrix – Global Test Strip Market, 2025 |
TABLE 16 Company Profiles – Key Players, Global Test Strip Market |
TABLE 17 Recent Developments & Strategic Announcements, 2023–2024 |
TABLE 18 Report Scope & Methodology Summary |
TABLE 19 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Global Test Strip Market Dynamics – Drivers, Restraints, and Opportunities |
FIGURE 2 Test Strip Market Industry Value Chain Analysis |
FIGURE 3 Porter's Five Forces Analysis – Test Strip Market |
FIGURE 4 Global Test Strip Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Test Strip Market Share, by Product, 2025 |
FIGURE 6 Test Strip Market Share, by Application, 2025 |
FIGURE 7 Test Strip Market Share, by End User, 2025 |
FIGURE 8 Test Strip Market Share, by Distribution Channel, 2025 |
FIGURE 9 Test Strip Market Revenue Share, by Region, 2025 |
FIGURE 10 North America Test Strip Market – Country Share, 2025 |
FIGURE 11 Europe Test Strip Market – Country Share, 2025 |
FIGURE 12 Asia-Pacific Test Strip Market – Country Share, 2025 |
FIGURE 13 South America Test Strip Market – Country Share, 2025 |
FIGURE 14 Middle East & Africa Test Strip Market – Country Share, 2025 |
FIGURE 15 Competitive Landscape – Market Share Analysis, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Blood Test Strips, Urine Test Strips	Blood Test Strips	Urine Test Strips
By Application	Diabetes, Pregnancy Detection, Urinary Tract Infection, Other Applications	Diabetes	Urinary Tract Infection
By End User	Hospitals & Clinics, Homecare / Personal Use, Other End Users	Homecare / Personal Use	Other End Users
By Distribution Channel	Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Channels	Retail Pharmacies	Online Pharmacies
By Region	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Blood Test Strips	Multi-analyte biosensor integration expanding beyond single glucose measurement
Urine Test Strips	Multi-parameter dipstick panels gaining traction for kidney function and UTI screening

Blood test strips remain the revenue cornerstone of the global market, driven by the massive installed base of personal glucometers and daily self-monitoring requirements. Urine test strips are experiencing above-average growth as clinical indications expand beyond pregnancy to include microalbuminuria, ketone, and infection screening in both institutional and home settings.

By Application

Sub-Segment	Key Trend
Diabetes	Connected strip ecosystems linking self-monitoring data to telehealth platforms
Pregnancy Detection	Stable replacement-cycle demand with rising digital-readout format preference
Urinary Tract Infection	Home pre-screening before telehealth antibiotic prescriptions
Other Applications	Cholesterol, ketone, and drug-of-abuse screening diversifying end-use cases

Diabetes dominates application-level demand, mirroring global disease burden. UTI screening is the fastest-growing application as telehealth providers recommend home dipstick testing before prescribing antibiotics, reducing unnecessary clinical visits.

By End User

Sub-Segment	Key Trend
Hospitals & Clinics	Automated urinalysis analyzers driving institutional strip procurement
Homecare / Personal Use	E-pharmacy subscription models improving patient adherence and reorder rates
Other End Users	Community health workers in LMICs deploying strip-based screening kits

Homecare and personal use now represent the largest end-user channel, reflecting a structural shift toward patient-directed diagnostics enabled by retail availability and connected meter platforms.

By Distribution Channel

Sub-Segment	Key Trend
Hospital Pharmacies	Formulary consolidation reducing SKU diversity within institutional settings
Retail Pharmacies	Private-label strip programs from CVS, Walgreens, and Apollo expanding share
Online Pharmacies	Auto-replenishment subscriptions locking in recurring consumer revenue
Other Channels	Government tenders and NGO procurement supporting emerging-market access

Online pharmacies are recording the fastest distribution growth, leveraging subscription logistics and doorstep delivery to improve chronic-disease patient adherence across both mature and emerging markets.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”